The study was performed while the delta variant was the dominant strain of coronavirus in Israel

A study of 200,000 Israeli adolescents shows that Pfizer's coronavirus vaccine is 93 percent effective in stopping symptoms of Covid-19, and almost as effective in protecting the immune system of the delta variant from the virus, researchers said Wednesday.

The study, conducted by researchers from Israel's health organization Clalit, Harvard University and Boston Children's Hospital, compared 94,354 young people between the ages of 12 and 18 who received the vaccine with the same number of unvaccinated people of the same age group.

The study was performed while the delta variant was the dominant strain of coronavirus in Israel, which led researchers to conclude that the vaccine was as effective in young people against the mutation as against earlier versions.... Read More: i24